-
2
-
-
10744230484
-
International League of Associations for Rheumatology Classification of Juvenile Idiopathic Arthritis: Second Revision, Edmonton, 2001
-
Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31 (2): 390-2 (Pubitemid 38160763)
-
(2004)
Journal of Rheumatology
, vol.31
, Issue.2
, pp. 390-392
-
-
Petty, R.E.1
Southwood, T.R.2
Manners, P.3
Baum, J.4
Glass, D.N.5
Goldenberg, J.6
He, X.7
Maldonado-Cocco, J.8
Orozco-Alcala, J.9
Prieur, A.-M.10
Suarez-Almazor, M.E.11
Woo, P.12
-
3
-
-
0029917351
-
Pediatric rheumatology in the United Kingdom: Data from the British pediatric rheumatology group national diagnostic register
-
Symmons DP, Jones M, Osborne J, et al. Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register. J Rheumatol 1996; 23 (11): 1975-80 (Pubitemid 26376127)
-
(1996)
Journal of Rheumatology
, vol.23
, Issue.11
, pp. 1975-1980
-
-
Symmons, D.P.M.1
Jones, M.2
Osborne, J.3
Sills, J.4
Southwood, T.R.5
Woo, P.6
-
4
-
-
70350455910
-
New advances in the management of juvenile idiopathic arthritis: I non-biological therapy
-
Beresford MW, Baildam EM. New advances in the management of juvenile idiopathic arthritis: I. Non-biological therapy. Arch Dis Child Educ Pract Ed 2009; 94 (5): 144-50
-
(2009)
Arch. Dis. Child Educ. Pract. Ed.
, vol.94
, Issue.5
, pp. 144-150
-
-
Beresford, M.W.1
Baildam, E.M.2
-
5
-
-
0031720762
-
Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997
-
Petty RE, Southwood TR, Baum J, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998; 25 (10): 1991-4 (Pubitemid 28459316)
-
(1998)
Journal of Rheumatology
, vol.25
, Issue.10
, pp. 1991-1994
-
-
Petty, R.E.1
Southwood, T.R.2
Baum, J.3
Bhettay, E.4
Glass, D.N.5
Manners, P.6
Maldonado-Cocco, J.7
Suarez-Almazor, M.8
Orozco-Alcala, J.9
Prieur, A.-M.10
-
6
-
-
0034096937
-
Validation of the proposed ILAR classification criteria for juvenile idiopathic arthritis
-
Foeldvari I, Bidde M. Validation of the proposed ILAR classification criteria for juvenile idiopathic arthritis. International League of Associations for Rheumatology. J Rheumatol 2000; 27 (4): 1069-72 (Pubitemid 30389770)
-
(2000)
Journal of Rheumatology
, vol.27
, Issue.4
, pp. 1069-1072
-
-
Foeldvari, I.1
Bidde, M.2
-
7
-
-
0035112765
-
Classification of chronic arthritides of childhood (juvenile idiopathic arthritis): Criticisms and suggestions to improve the efficacy of the Santiago-Durban criteria [3]
-
Fantini F. Classification of chronic arthritides of childhood (juvenile idiopathic arthritis): criticisms and suggestions to improve the efficacy of the Santiago-Durban criteria. J Rheumatol 2001; 28 (2): 456-9 (Pubitemid 32165171)
-
(2001)
Journal of Rheumatology
, vol.28
, Issue.2
, pp. 456-459
-
-
Fantini, F.1
-
8
-
-
0035024702
-
Juvenile idiopathic arthritides evaluated prospectively in a single center according to the durban criteria
-
Hofer MF, Mouy R, Prieur AM. Juvenile idiopathic arthritides evaluated prospectively in a single center according to the Durban criteria. J Rheumatol 2001; 28 (5): 1083-90 (Pubitemid 32422594)
-
(2001)
Journal of Rheumatology
, vol.28
, Issue.5
, pp. 1083-1090
-
-
Hofer, M.F.1
Mouy, R.2
Prieur, A.-M.3
-
9
-
-
79955093416
-
US Department of health & human services
-
online Available from Mar 2, Accessed
-
US Department of Health & Human Services. US Food and Drug Administration [online]. Available from URL: http://www.fda.gov [Accessed 2011 Mar 2]
-
(2011)
US Food and Drug Administration
-
-
-
10
-
-
84883519386
-
-
European Medicines Agency Committee forMedicinal Products for Human Use CHMP. CPMP/EWP/422/04 [online]. Available from URL: Accessed Jan 27
-
European Medicines Agency, Committee forMedicinal Products for Human Use (CHMP). Guideline on clinical investigation of medicinal products for the treatment of juvenile idiopathic arthritis. CPMP/EWP/422/04 [online]. Available from URL: http://www.ema.europa.eu/pdfs/human/ewp/042204en.pdf [Accessed 2011 Jan 27]
-
(2011)
Guideline on Clinical Investigation of Medicinal Products for The Treatment of Juvenile Idiopathic Arthritis
-
-
-
11
-
-
73649102432
-
Juvenile idiopathic arthritis: Classification clinical presentation and current treatments
-
72 Suppl
-
Dannecker GE, Quartier P. Juvenile idiopathic arthritis: classification, clinical presentation and current treatments. Horm Res 2009; 72 Suppl. 1: 4-12
-
(2009)
Horm. Res.
, vol.1
, pp. 4-12
-
-
Dannecker, G.E.1
Quartier, P.2
-
12
-
-
33847287323
-
Juvenile idiopathic arthritis
-
Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007; 369 (9563): 767-78
-
(2007)
Lancet
, vol.369
, Issue.9563
, pp. 767-778
-
-
Ravelli, A.1
Martini, A.2
-
13
-
-
49749135691
-
A comprehensive review of the genetics of juvenile idiopathic arthritis abstract
-
Prahalad S, Glass DN. A comprehensive review of the genetics of juvenile idiopathic arthritis [abstract]. Pediatr Rheumatol Online J 2008; 6: 11
-
(2008)
Pediatr. Rheumatol. Online J.
, vol.6
, pp. 11
-
-
Prahalad, S.1
Glass, D.N.2
-
14
-
-
77649237975
-
Environmental factors and the geoepidemiology of juvenile idiopathic arthritis
-
Berkun Y, Padeh S. Environmental factors and the geoepidemiology of juvenile idiopathic arthritis. Autoimmun Rev 2010; 9 (5): A319-24
-
(2010)
Autoimmun. Rev.
, vol.9
, Issue.5
-
-
Berkun, Y.1
Padeh, S.2
-
15
-
-
77950546441
-
Possible environmental determinants of juvenile idiopathic arthritis
-
Oxford
-
Ellis JA, Munro JE, Ponsonby AL. Possible environmental determinants of juvenile idiopathic arthritis. Rheumatology (Oxford) 2010; 49 (3): 411-25
-
(2010)
Rheumatology
, vol.49
, Issue.3
, pp. 411-425
-
-
Ellis, J.A.1
Munro, J.E.2
Ponsonby, A.L.3
-
16
-
-
0035023255
-
Growing pains: The ILAR classification of juvenile idiopathic arthritis
-
Petty RE. Growing pains: the ILAR classification of juvenile idiopathic arthritis. J Rheumatol 2001; 28 (5): 927-8 (Pubitemid 32422567)
-
(2001)
Journal of Rheumatology
, vol.28
, Issue.5
, pp. 927-928
-
-
Petty, R.E.1
-
17
-
-
15044365210
-
Classification criteria for juvenile idiopathic arthritis in Spanish children
-
Evaluation of revised International League of Associations for Rheumatology Spanish children Edmonton 2001
-
Merino R, de Inocencio J, Garcia-Consuegra J. Evaluation of revised International League of Associations for Rheumatology classification criteria for juvenile idiopathic arthritis in (Edmonton 2001). J Rheumatol 2005; 32 (3): 559-61
-
(2005)
J. Rheumatol.
, vol.32
, Issue.3
, pp. 559-561
-
-
Merino, R.1
De Inocencio, J.2
Garcia-Consuegra, J.3
-
18
-
-
33845570843
-
-
Focus on juvenile idiopathic arthritis according to the 2001 Edmonton revised classification from the International League of Associations for Rheumatology: an Italian experience
-
Stabile A, Avallone L, Compagnone A, et al. Focus on juvenile idiopathic arthritis according to the 2001 Edmonton revised classification from the International League of Associations for Rheumatology: an Italian experience. Eur Rev Med Pharmacol Sci 2006; 10 (5): 229-34
-
(2006)
Eur. Rev. Med. Pharmacol. Sci.
, vol.10
, Issue.5
, pp. 229-234
-
-
Stabile, A.1
Avallone, L.2
Compagnone, A.3
-
19
-
-
41749123412
-
Juvenile idiopathic arthritis: Clinical subgroups and classification
-
102-6 108-10
-
Minden K, Niewerth M. Juvenile idiopathic arthritis: clinical subgroups and classification. Z Rheumatol 2008; 67 (2): 100, 102-6, 108-10
-
(2008)
Z. Rheumatol.
, vol.67
, Issue.2
, pp. 100
-
-
Minden, K.1
Niewerth, M.2
-
20
-
-
33846231470
-
Juvenile idiopathic arthritis classification criteria: Loopholes and diagnosis software [3]
-
Behrens EM, Beukelman T, Cron RQ. Juvenile idiopathic arthritis classification criteria: loopholes and diagnosis software. J Rheumatol 2007; 34 (1): 234; author reply 234-5 (Pubitemid 46106593)
-
(2007)
Journal of Rheumatology
, vol.34
, Issue.1
, pp. 234
-
-
Behrens, E.M.1
Beukelman, T.2
Cron, R.Q.3
-
21
-
-
54949114697
-
HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis
-
Berntson L,Damgard M, Andersson-Gare B, et al. HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis. J Rheumatol 2008; 35 (10): 2055-61
-
(2008)
J. Rheumatol.
, vol.35
, Issue.10
, pp. 2055-2061
-
-
Berntson, L.1
Damgard, M.2
Andersson-Gare, B.3
-
22
-
-
67650045888
-
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets
-
Griffin TA, Barnes MG, Ilowite NT, et al. Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets. Arthritis Rheum2009; 60 (7): 2113-23
-
(2009)
Arthritis Rheum.
, vol.60
, Issue.7
, pp. 2113-2123
-
-
Griffin, T.A.1
Barnes, M.G.2
Ilowite, N.T.3
-
23
-
-
65849277982
-
Early diagnosis of temporomandibular joint involvement in juvenile idiopathic arthritis: A pilot study comparing clinical examination and ultrasound to magnetic resonance imaging
-
Oxford
-
Muller L, Kellenberger CJ, Cannizzaro E, et al. Early diagnosis of temporomandibular joint involvement in juvenile idiopathic arthritis: a pilot study comparing clinical examination and ultrasound to magnetic resonance imaging. Rheumatology (Oxford) 2009; 48 (6): 680-5
-
(2009)
Rheumatology
, vol.48
, Issue.6
, pp. 680-685
-
-
Muller, L.1
Kellenberger, C.J.2
Cannizzaro, E.3
-
24
-
-
70449514536
-
Comparison of clinical versus ultrasound-determined synovitis in juvenile idiopathic arthritis
-
Magni-Manzoni S, Epis O, Ravelli A, et al. Comparison of clinical versus ultrasound-determined synovitis in juvenile idiopathic arthritis. Arthritis Rheum 2009; 61 (11): 1497-504
-
(2009)
Arthritis Rheum.
, vol.61
, Issue.11
, pp. 1497-1504
-
-
Magni-Manzoni, S.1
Epis, O.2
Ravelli, A.3
-
25
-
-
77954429815
-
The detection of subclinical synovitis by ultrasound in oligoarticular juvenile idiopathic arthritis: A pilot study
-
Oxford
-
Haslam KE, McCann LJ,Wyatt S, et al. The detection of subclinical synovitis by ultrasound in oligoarticular juvenile idiopathic arthritis: a pilot study. Rheumatology (Oxford) 2010; 49 (1): 123-7
-
(2010)
Rheumatology
, vol.49
, Issue.1
, pp. 123-127
-
-
Haslam, K.E.1
McCann, L.J.2
Wyatt, S.3
-
26
-
-
78149258247
-
Prospective evaluation of clinical and ultrasound findings in ankle disease in juvenile idiopathic arthritis: Importance of ankle ultrasound
-
Pascoli L, Wright S, McAllister C, et al. Prospective evaluation of clinical and ultrasound findings in ankle disease in juvenile idiopathic arthritis: importance of ankle ultrasound. J Rheumatol 2010; 37 (11): 2409-14
-
(2010)
J. Rheumatol.
, vol.37
, Issue.11
, pp. 2409-2414
-
-
Pascoli, L.1
Wright, S.2
McAllister, C.3
-
27
-
-
77954438269
-
Synovial and inflammatory diseases in childhood: Role of new imaging modalities in the assessment of patients with juvenile idiopathic arthritis
-
Damasio MB, Malattia C, Martini A, et al. Synovial and inflammatory diseases in childhood: role of new imaging modalities in the assessment of patients with juvenile idiopathic arthritis. Pediatr Radiol 2010; 40 (6): 985-98
-
(2010)
Pediatr. Radiol.
, vol.40
, Issue.6
, pp. 985-998
-
-
Damasio, M.B.1
Malattia, C.2
Martini, A.3
-
28
-
-
65649139152
-
Evidence-based outcomes of studies addressing diagnostic accuracy of MRI of juvenile idiopathic arthritis
-
Miller E, Uleryk E, Doria AS. Evidence-based outcomes of studies addressing diagnostic accuracy of MRI of juvenile idiopathic arthritis. AJR Am J Roentgenol 2009; 192 (5): 1209-18
-
(2009)
AJR Am. J. Roentgenol.
, vol.192
, Issue.5
, pp. 1209-1218
-
-
Miller, E.1
Uleryk, E.2
Doria, A.S.3
-
29
-
-
77953270386
-
Imaging juvenile idiopathic arthritis: Assessing the modalities
-
McKay GM, Cox LA, Long BW. Imaging juvenile idiopathic arthritis: assessing the modalities. Radiol Technol 2010; 81 (4): 318-27
-
(2010)
Radiol. Technol.
, vol.81
, Issue.4
, pp. 318-327
-
-
McKay, G.M.1
Cox, L.A.2
Long, B.W.3
-
30
-
-
44849099605
-
BSPAR position statement on professionals working in paediatric rheumatology
-
DOI 10.1093/rheumatology/ken069
-
Baildam E, Davidson J. BSPAR position statement on professionals working in paediatric rheumatology. Rheumatology (Oxford) 2008; 47 (6): 743-4 (Pubitemid 351796354)
-
(2008)
Rheumatology
, vol.47
, Issue.6
, pp. 743-744
-
-
Baildam, E.1
Davidson, J.2
-
31
-
-
77954188304
-
BSPAR standards of care for children and young people with juvenile idiopathic arthritis
-
Oxford
-
Davies K, Cleary G, Foster H, et al. BSPAR standards of care for children and young people with juvenile idiopathic arthritis. Rheumatology (Oxford) 2010; 49 (7): 1406-8
-
(2010)
Rheumatology
, vol.49
, Issue.7
, pp. 1406-1408
-
-
Davies, K.1
Cleary, G.2
Foster, H.3
-
32
-
-
77954187504
-
Developing standards of care for patients with juvenile idiopathic arthritis
-
Oxford
-
Wallace CA. Developing standards of care for patients with juvenile idiopathic arthritis. Rheumatology (Oxford) 2010; 49 (7): 1213-4
-
(2010)
Rheumatology
, vol.49
, Issue.7
, pp. 1213-1214
-
-
Wallace, C.A.1
-
33
-
-
72049103194
-
Developing outcome measures for paediatric rheumatic diseases
-
Brunner HI, Ravelli A. Developing outcome measures for paediatric rheumatic diseases. Best Pract Res Clin Rheumatol 2009; 23 (5): 609-24
-
(2009)
Best. Pract. Res. Clin. Rheumatol.
, vol.23
, Issue.5
, pp. 609-624
-
-
Brunner, H.I.1
Ravelli, A.2
-
34
-
-
34548301943
-
Measuring clinical response and remission in juvenile idiopathic arthritis
-
DOI 10.1097/BOR.0b013e32825a6a68, PII 0000228120070900000013
-
Ringold S,Wallace CA. Measuring clinical response and remission in juvenile idiopathic arthritis. Curr Opin Rheumatol 2007; 19 (5): 471-6 (Pubitemid 47344240)
-
(2007)
Current Opinion in Rheumatology
, vol.19
, Issue.5
, pp. 471-476
-
-
Ringold, S.1
Wallace, C.A.2
-
35
-
-
4344638042
-
International research networks in pediatric rheumatology: The PRINTO perspective
-
DOI 10.1097/01.bor.0000130286.54383.ea
-
Ruperto N, Martini A. International research networks in pediatric rheumatology: the PRINTO perspective. Curr Opin Rheumatol 2004; 16 (5): 566-70 (Pubitemid 39128326)
-
(2004)
Current Opinion in Rheumatology
, vol.16
, Issue.5
, pp. 566-570
-
-
Ruperto, N.1
Martini, A.2
-
36
-
-
0030960980
-
Preliminary definition of improvement in juvenile arthritis
-
Giannini EH, Ruperto N, Ravelli A, et al. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997; 40 (7): 1202-9 (Pubitemid 27430130)
-
(1997)
Arthritis and Rheumatism
, vol.40
, Issue.7
, pp. 1202-1209
-
-
Giannini, E.H.1
Ruperto, N.2
Ravelli, A.3
Lovell, D.J.4
Felson, D.T.5
Martini, A.6
-
37
-
-
0012603260
-
ACR formally adopts improvement criteria for juvenile arthritis
-
ACR pediatric 30
-
Albornoz MA. ACR formally adopts improvement criteria for juvenile arthritis (ACR pediatric 30). ACR News 2002; 21: 3
-
(2002)
ACR News
, vol.21
, pp. 3
-
-
Albornoz, M.A.1
-
38
-
-
17144470407
-
The British version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ)
-
Nugent J, Ruperto N, Grainger J, et al. The British version of the childhood health questionnaire (CHAQ) and the child health questionnaire (CHQ). Clin Exp Rheumatol 2001; 19 Suppl. 23: S163-7 (Pubitemid 33730209)
-
(2001)
Clinical and Experimental Rheumatology
, vol.19
, Issue.4 SUPPL. 23
-
-
Nugent, J.1
Ruperto, N.2
Grainger, J.3
Machado, C.4
Sawhney, S.5
Baildam, E.6
Davidson, J.7
Foster, H.8
Hall, A.9
Hollingworth, P.10
Sills, J.11
Venning, H.12
Walsh, J.E.13
Landgraf, J.M.14
Roland, M.15
Woo, P.16
Murray, K.J.17
-
39
-
-
15444352940
-
Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate
-
Ruperto N, Ravelli A, Falcini F, et al. Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate. Italian Pediatric Rheumatology Study Group. Ann Rheum Dis 1998; 57 (1): 38-41 (Pubitemid 28175218)
-
(1998)
Annals of the Rheumatic Diseases
, vol.57
, Issue.1
, pp. 38-41
-
-
Ruperto, N.1
Ravelli, A.2
Falcini, F.3
Lepore, L.4
De Sanctis, R.5
Zulian, F.6
Buoncompagni, A.7
Sardella, M.L.8
Strano, C.9
Alessio, M.10
Viola, S.11
Martini, A.12
-
40
-
-
0036256812
-
Preliminary definition of disease flare in juvenile rheumatoid arthritis
-
BrunnerHI, Lovell DJ, Finck BK, et al. Preliminary definition of disease flare in juvenile rheumatoid arthritis. J Rheumatol 2002; 29 (5): 1058-64 (Pubitemid 34493514)
-
(2002)
Journal of Rheumatology
, vol.29
, Issue.5
, pp. 1058-1064
-
-
Brunner, H.I.1
Lovell, D.J.2
Finck, B.K.3
Giannini, E.H.4
-
41
-
-
7544222361
-
Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis
-
Wallace CA, Ruperto N, Giannini E. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004; 31 (11): 2290-4 (Pubitemid 39453253)
-
(2004)
Journal of Rheumatology
, vol.31
, Issue.11
, pp. 2290-2294
-
-
Wallace, C.A.1
Ruperto, N.2
Giannini, E.H.3
-
42
-
-
33645833004
-
Preliminary validation of clinical remission criteria using the Omeract filter for select categories of juvenile idiopathic arthritis
-
Wallace CA, Ravelli A, Huang B, et al. Preliminary validation of clinical remission criteria using the OMERACT filter for select categories of juvenile idiopathic arthritis. J Rheumatol 2006; 33 (4): 789-95
-
(2006)
J. Rheumatol.
, vol.33
, Issue.4
, pp. 789-795
-
-
Wallace, C.A.1
Ravelli, A.2
Huang, B.3
-
43
-
-
27744525152
-
Patterns of clinical remission in select categories of juvenile idiopathic arthritis
-
DOI 10.1002/art.21389
-
Wallace CA, Huang B, Bandeira M, et al. Patterns of clinical remission in select categories of juvenile idiopathic arthritis. Arthritis Rheum 2005; 52 (11): 3554-62 (Pubitemid 41612224)
-
(2005)
Arthritis and Rheumatism
, vol.52
, Issue.11
, pp. 3554-3562
-
-
Wallace, C.A.1
Huang, B.2
Bandeira, M.3
Ravelli, A.4
Giannini, E.H.5
-
44
-
-
48349093002
-
Abatacept in children with juvenile idiopathic arthritis: A randomised double-blind placebo-controlled withdrawal trial
-
Ruperto N, Lovell DJ, Quartier P, et al. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial. Lancet 2008; 372 (9636): 383-91
-
(2008)
Lancet
, vol.372
, Issue.9636
, pp. 383-391
-
-
Ruperto, N.1
Lovell, D.J.2
Quartier, P.3
-
45
-
-
49549118435
-
Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis
-
Magni-Manzoni S, Ruperto N, Pistorio A, et al. Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis. Arthritis Rheum 2008; 59 (8): 1120-7
-
(2008)
Arthritis Rheum.
, vol.59
, Issue.8
, pp. 1120-1127
-
-
Magni-Manzoni, S.1
Ruperto, N.2
Pistorio, A.3
-
46
-
-
33846987171
-
Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis
-
The Pediatric Rheumatology International Trials Organization Multinational Quality of Life Cohort Study
-
Oliveira S, Ravelli A, Pistorio A, et al. Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis. The Pediatric Rheumatology International Trials Organization Multinational Quality of Life Cohort Study. Arthritis Rheum 2007; 57 (1): 35-43
-
(2007)
Arthritis. Rheum.
, vol.57
, Issue.1
, pp. 35-43
-
-
Oliveira, S.1
Ravelli, A.2
Pistorio, A.3
-
47
-
-
33846676220
-
Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort study
-
DOI 10.1093/rheumatology/kel218
-
Gutierrez-Suarez R, Pistorio A, Cespedes CA, et al. Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort study. Rheumatology (Oxford) 2007; 46 (2): 314-20 (Pubitemid 46193945)
-
(2007)
Rheumatology
, vol.46
, Issue.2
, pp. 314-320
-
-
Gutierrez-Suarez, R.1
Pistorio, A.2
Cespedes Cruz, A.3
Norambuena, X.4
Flato, B.5
Rumba, I.6
Harjacek, M.7
Nielsen, S.8
Susic, G.9
Mihaylova, D.10
Huemer, C.11
Melo-Gomes, J.12
Andersson-Gare, B.13
Balogh, Z.14
De Cunto, C.15
Vesely, R.16
Pagava, K.17
Romicka, A.M.18
Burgos-Vargas, R.19
Martini, A.20
Ruperto, N.21
more..
-
48
-
-
0036008765
-
The PedsQL™ in pediatric rheumatology: Reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory™ Generic Core Scales and Rheumatology Module
-
DOI 10.1002/art.10095
-
Varni JW, Seid M, Smith KT, et al. The PedsQL in pediatric rheumatology: reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory Generic Core Scales and Rheumatology Module. Arthritis Rheum 2002; 46 (3): 714-25 (Pubitemid 34214252)
-
(2002)
Arthritis and Rheumatism
, vol.46
, Issue.3
, pp. 714-725
-
-
Varni, J.W.1
Seid, M.2
Knight, T.S.3
Burwinkle, T.4
Brown, J.5
Szer, I.S.6
-
49
-
-
0348161127
-
The PedsQL™*4.0 as a pediatric population health measure: Feasibility, reliability, and validity
-
DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2
-
Varni JW, Burwinkle TM, Seid M, et al. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr 2003; 3 (6): 329-41 (Pubitemid 37527280)
-
(2003)
Ambulatory Pediatrics
, vol.3
, Issue.6
, pp. 329-341
-
-
Varni, J.W.1
Burwinkle, T.M.2
Seid, M.3
Skarr, D.4
-
50
-
-
66249138135
-
Development and validation of a composite disease activity score for juvenile idiopathic arthritis
-
Consolaro A, Ruperto N, Bazso A, et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 2009; 61 (5): 658-66
-
(2009)
Arthritis Rheum.
, vol.61
, Issue.5
, pp. 658-666
-
-
Consolaro, A.1
Ruperto, N.2
Bazso, A.3
-
51
-
-
22244452029
-
Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis
-
DOI 10.1002/art.21119
-
Viola S, Felici E, Magni-Manzoni S, et al. Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis. Arthritis Rheum 2005; 52 (7): 2092-102 (Pubitemid 40994332)
-
(2005)
Arthritis and Rheumatism
, vol.52
, Issue.7
, pp. 2092-2102
-
-
Viola, S.1
Felici, E.2
Magni-Manzoni, S.3
Pistorio, A.4
Buoncompagni, A.5
Ruperto, N.6
Rossi, F.7
Bartoli, M.8
Martini, A.9
Ravelli, A.10
-
52
-
-
41849105404
-
The time has come to include assessment of radiographic progression in juvenile idiopathic arthritis clinical trials
-
Ravelli A. The time has come to include assessment of radiographic progression in juvenile idiopathic arthritis clinical trials. J Rheumatol 2008; 35 (4): 553-7 (Pubitemid 351500048)
-
(2008)
Journal of Rheumatology
, vol.35
, Issue.4
, pp. 553-557
-
-
Ravelli, A.1
-
53
-
-
42949116861
-
Improving the evidence base for treatment of juvenile idiopathic arthritis: The challenge and opportunity facing the MCRN/ARC Paediatric Rheumatology Clinical Studies Group
-
DOI 10.1093/rheumatology/ken055
-
Thornton J, Beresford MW, Clayton P. Improving the evidence base for treatment of juvenile idiopathic arthritis: the challenge and opportunity facing the MCRN/ARC Paediatric Rheumatology Clinical Studies Group. Rheumatology (Oxford) 2008; 47 (5): 563-6 (Pubitemid 351619190)
-
(2008)
Rheumatology
, vol.47
, Issue.5
, pp. 563-566
-
-
Thornton, J.1
Beresford, M.W.2
Clayton, P.3
-
54
-
-
10044225800
-
Comparison of the intraarticular effectiveness of triamcinolone hexacetonide and triamcinolone acetonide in treatment of juvenile rheumatoid arthritis
-
Eberhard BA. Comparison of the intraarticular effectiveness of triamcinolone hexacetonide and triamcinolone acetonide in treatment of juvenile rheumatoid arthritis. J Rheumatol 2004; 31 (12): 2507-12 (Pubitemid 39603105)
-
(2004)
Journal of Rheumatology
, vol.31
, Issue.12
, pp. 2507-2512
-
-
Eberhard, B.A.1
Sison, M.C.2
Gottlieb, B.S.3
Ilowite, N.T.4
-
55
-
-
5444237618
-
Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: A double-blind trial
-
DOI 10.1093/rheumatology/keh313
-
Zulian F. Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial. Rheumatology (Oxford) 2004; 43 (10): 1288-91 (Pubitemid 39359306)
-
(2004)
Rheumatology
, vol.43
, Issue.10
, pp. 1288-1291
-
-
Zulian, F.1
Martini, G.2
Gobber, D.3
Plebani, M.4
Zacchello, F.5
Manners, P.6
-
56
-
-
0141962659
-
Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis
-
DOI 10.1093/rheumatology/keg358
-
Zulian F. Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis. Rheumatology (Oxford) 2003; 42(10): 1254-9 (Pubitemid 37258492)
-
(2003)
Rheumatology
, vol.42
, Issue.10
, pp. 1254-1259
-
-
Zulian, F.1
Martini, G.2
Gobber, D.3
Agosto, C.4
Gigante, C.5
Zacchello, F.6
-
57
-
-
0036709133
-
Treatment of juvenile idiopathic arthritis with intra-articular triamcinolone hexacetonide: Evaluation of clinical effectiveness correlated with circulating ANA and T γ/δ + and B CD5 + lymphocyte populations of synovial fluid
-
Lepore L. Treatment of juvenile idiopathic arthritis with intra-articular triamcinolone hexacetonide: evaluation of clinical effectiveness correlated with circulatingANAand T gamma/delta + and B CD5+ lymphocyte populations of synovial fluid. Clin Exp Rheumatol 2002; 20 (5): 719-22 (Pubitemid 35243789)
-
(2002)
Clinical and Experimental Rheumatology
, vol.20
, Issue.5
, pp. 719-722
-
-
Lepore, L.1
Del Santo, M.2
Malorgio, C.3
Presani, G.4
Perticarari, S.5
Prodan, M.6
Di Leo, G.7
Leone, V.8
Tommasini, A.9
-
58
-
-
40049106242
-
Factors Influencing the efficacy of intra-articular steroid injections in patients with juvenile idiopathic arthritis
-
DOI 10.1007/s00431-007-0525-9
-
Marti P. Factors influencing the efficacy of intra-articular steroid injections in patients with juvenile idiopathic arthritis. Eur J Pediatr 2008; 167 (4): 425-30 (Pubitemid 351322475)
-
(2008)
European Journal of Pediatrics
, vol.167
, Issue.4
, pp. 425-430
-
-
Marti, P.1
Molinari, L.2
Bolt, I.B.3
Seger, R.4
Saurenmann, R.K.5
-
60
-
-
0037374081
-
Intra-articular corticosteroid injections in juvenile idiopathic arthritis
-
DOI 10.1136/adc.88.3.192
-
Cleary AG, Murphy HD, Davidson JE. Intra-articular corticosteriod injections in juvenile idiopathic arthritis. Arch Dis Child 2003; 88: 192-6 (Pubitemid 36269496)
-
(2003)
Archives of Disease in Childhood
, vol.88
, Issue.3
, pp. 192-196
-
-
Cleary, A.G.1
Murphy, H.D.2
Davidson, J.E.3
-
61
-
-
33845619137
-
HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
-
DOI 10.1002/pbc.21039
-
Henter JI, Horne A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48 (2): 124-31 (Pubitemid 44958267)
-
(2007)
Pediatric Blood and Cancer
, vol.48
, Issue.2
, pp. 124-131
-
-
Henter, J.-I.1
Horne, A.2
Arico, M.3
Egeler, R.M.4
Filipovich, A.H.5
Imashuku, S.6
Ladisch, S.7
McClain, K.8
Webb, D.9
Winiarski, J.10
Janka, G.11
-
62
-
-
0026609159
-
Methotrexate in resistant juvenile rheumatoid arthritis: Results of the USA-USSR double-blind placebo-controlled trial
-
The Pediatric Rheumatology Collaborative Study Group and The Cooperative Childrens Study Group.
-
Giannini EH. Methotrexate in resistant juvenile rheumatoid arthritis: results of the USA-USSR double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Childrens Study Group. N Engl J Med 1992; 326 (16): 1043-9
-
(1992)
N. Engl. J. Med.
, vol.326
, Issue.16
, pp. 1043-1049
-
-
Giannini, E.H.1
-
63
-
-
0033875824
-
Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis
-
Woo P. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum 2000; 43 (8): 1849-57
-
(2000)
Arthritis Rheum.
, vol.43
, Issue.8
, pp. 1849-1857
-
-
Woo, P.1
-
65
-
-
3142746016
-
A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate
-
DOI 10.1002/art.20288
-
Ruperto N. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis Rheum 2004; 50 (7): 2191-201 (Pubitemid 38924397)
-
(2004)
Arthritis and Rheumatism
, vol.50
, Issue.7
, pp. 2191-2201
-
-
Ruperto, N.1
Murray, K.J.2
Gerloni, V.3
Wulffraat, N.4
De Oliveira, S.K.F.5
Falcini, F.6
Dolezalova, P.7
Alessio, M.8
Burgos-Vargas, R.9
Corona, F.10
Vesely, R.11
Foster, H.12
Davidson, J.13
Zulian, F.14
Asplin, L.15
Baildam, E.16
Consuegra, J.G.17
Ozdogan, H.18
Saurenmann, R.19
Joos, R.20
Pistorio, A.21
Woo, P.22
Martini, A.23
more..
-
66
-
-
39549087440
-
Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis
-
DOI 10.1136/ard.2007.075895
-
Cespedes-Cruz A, Gutierrez-Suarez R, Pistorio A, et al. Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis. Ann Rheum Dis 2008; 67 (3): 309-14 (Pubitemid 351281263)
-
(2008)
Annals of the Rheumatic Diseases
, vol.67
, Issue.3
, pp. 309-314
-
-
Cespedes-Cruz, A.1
Gutierrez-Suarez, R.2
Pistorio, A.3
Ravelli, A.4
Loy, A.5
Murray, K.J.6
Gertoni, V.7
Wulffraat, N.8
Oliveira, S.9
Walsh, J.10
Calvo Penades, I.11
Alpigiani, M.G.12
Lahdenne, P.13
Saad-Magalhaes, C.14
Cortis, E.15
Lepore, L.16
Kimura, Y.17
Wouters, C.18
Martini, A.19
Ruperto, N.20
more..
-
67
-
-
1642580540
-
Methotrexate treatment in juvenile idiopathic arthritis: When is the right time to stop?
-
DOI 10.1136/ard.2003.005686
-
Foell D, Frosch M, Schulze zur WA, et al. Methotrexate treatment in juvenile idiopathic arthritis: when is the right time to stop? Ann Rheum Dis 2004; 63 (2): 206-8 (Pubitemid 38122142)
-
(2004)
Annals of the Rheumatic Diseases
, vol.63
, Issue.2
, pp. 206-208
-
-
Foell, D.1
Frosch, M.2
Schulze Zur Wiesch, A.3
Vogl, T.4
Sorg, C.5
Roth, J.6
-
68
-
-
77950512831
-
Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: A randomized clinical trial
-
Foell D, Wulffraat N, Wedderburn LR, et al. Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA 2010; 303 (13): 1266-73
-
(2010)
JAMA
, vol.303
, Issue.13
, pp. 1266-1273
-
-
Foell, D.1
Wulffraat, N.2
Wedderburn, L.R.3
-
69
-
-
77649122248
-
Biologic predictors of extension of oligoarticular juvenile idiopathic arthritis as determined from synovial fluid cellular composition and gene expression
-
Hunter PJ, Nistala K, Jina N, et al. Biologic predictors of extension of oligoarticular juvenile idiopathic arthritis as determined from synovial fluid cellular composition and gene expression. Arthritis Rheum 2010; 62 (3): 896-907
-
(2010)
Arthritis Rheum.
, vol.62
, Issue.3
, pp. 896-907
-
-
Hunter, P.J.1
Nistala, K.2
Jina, N.3
-
70
-
-
0031969434
-
Sulfasalazine in the treatment of juvenile chronic arthritis: A randomized, double-blind, placebo-controlled, multicenter study
-
DOI 10.1002/1529-0131(199805)41:5<808::AID-ART6>3.0.CO;2-T
-
Van Rossum MA. Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group. Arthritis Rheum 1998; 41 (5): 808-16 (Pubitemid 28225780)
-
(1998)
Arthritis and Rheumatism
, vol.41
, Issue.5
, pp. 808-816
-
-
Van Rossum, M.A.J.1
Fiselier, T.J.W.2
Franssen, M.J.A.M.3
Zwinderman, A.H.4
Ten Cate, R.5
Van Suijlekom-Smit, L.W.A.6
Van Luijk, W.H.J.7
Van Soesbergen, R.M.8
Wulffraat, N.M.9
Oostveen, J.C.M.10
Kuis, W.11
Dijkstra, P.F.12
Van Ede, C.F.P.13
Dijkmans, B.A.C.14
-
71
-
-
35648952854
-
Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: Sustained benefits of early sulfasalazine treatment
-
DOI 10.1136/ard.2006.064717
-
Van Rossum MA. Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment. Ann Rheum Dis 2007; 66 (11): 1518-24 (Pubitemid 350032663)
-
(2007)
Annals of the Rheumatic Diseases
, vol.66
, Issue.11
, pp. 1518-1524
-
-
Van Rossum, M.A.J.1
Van Soesbergen, R.M.2
Boers, M.3
Zwinderman, A.H.4
Fiselier, T.J.W.5
Franssen, M.J.A.M.6
Ten Cate, R.7
Van Suijlekom-Smit, L.W.A.8
Wulffraat, N.M.9
Van Luijk, W.H.J.10
Oostveen, J.C.M.11
Kuis, W.12
Dijkmans, B.A.C.13
-
72
-
-
0035901624
-
Rational use of new and existing disease-modifying agents in rheumatoid arthritis
-
Kremer JM. Rational use of new and existing disease-modifying agents in rheumatoid arthritis. Ann Intern Med 2001; 134 (8): 695-706 (Pubitemid 32322246)
-
(2001)
Annals of Internal Medicine
, vol.134
, Issue.8
, pp. 695-706
-
-
Kremer, J.M.1
-
73
-
-
34548359264
-
Recognition and management of macrophage activation syndrome in juvenile arthritis
-
DOI 10.1097/BOR.0b013e32825a6a79, PII 0000228120070900000014
-
Kelly A,RamananAV. Recognition and management of macrophage activation syndrome in juvenile arthritis. Curr Opin Rheumatol 2007; 19 (5): 477-81 (Pubitemid 47344241)
-
(2007)
Current Opinion in Rheumatology
, vol.19
, Issue.5
, pp. 477-481
-
-
Kelly, A.1
Ramanan, A.V.2
-
74
-
-
33751428674
-
Autologous haematopoeitic stem cell rescue (AHSCR) for severe rheumatic disease in children: Guidance for BSPAR members - Executive summary
-
DOI 10.1093/rheumatology/kel319a
-
Foster H. Autologous haematopoeitic stem cell rescue (AHSCR) for severe rheumatic disease in children: guidance for BSPAR members. Executive summary. Rheumatology (Oxford) 2006; 45 (12): 1570-1 (Pubitemid 44817067)
-
(2006)
Rheumatology
, vol.45
, Issue.12
, pp. 1570-1571
-
-
Foster, H.1
Davidson, J.2
Baildam, E.3
Abinun, M.4
Wedderburn, L.R.5
-
75
-
-
34547458668
-
Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: Long-term followup of a prospective clinical trial
-
DOI 10.1002/art.22656
-
Brinkman DM. Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial. Arthritis Rheum 2007; 56 (7): 2410-21 (Pubitemid 47173589)
-
(2007)
Arthritis and Rheumatism
, vol.56
, Issue.7
, pp. 2410-2421
-
-
Brinkman, D.M.C.1
De Kleer, I.M.2
Ten Cate, R.3
Van Rossum, M.A.J.4
Bekkering, W.P.5
Fasth, A.6
Van Tol, M.J.D.7
Kuis, W.8
Wulffraat, N.M.9
Vossen, J.M.10
-
76
-
-
69549155771
-
Autologous T cell depleted haematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK 2000-2007
-
Abinun M, Flood TJ, Cant AJ, et al. Autologous T cell depleted haematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK (2000-2007). Mol Immunol 2009; 47 (1): 46-51
-
(2009)
Mol. Immunol.
, vol.47
, Issue.1
, pp. 46-51
-
-
Abinun, M.1
Flood, T.J.2
Cant, A.J.3
-
77
-
-
70350449256
-
New advances in the management of juvenile idiopathic arthritis: II
-
The era of biologicals
-
Beresford MW, Baildam EM. New advances in the management of juvenile idiopathic arthritis: II. The era of biologicals. Arch Dis Child Educ Pract Ed 2009; 94 (5): 151-6
-
(2009)
Arch. Dis. Child. Educ. Pract. Ed.
, vol.94
, Issue.5
, pp. 151-156
-
-
Beresford, M.W.1
Baildam, E.M.2
-
78
-
-
33845882484
-
Biologic therapies in rheumatology: Lessons learned, future directions
-
DOI 10.1038/nrd2196, PII NRD2196
-
Strand V, Kimberly R, Isaacs JD. Biologic therapies in rheumatology: lessons learned, future directions. Nat Rev Drug Discov 2007; 6 (1): 75-92 (Pubitemid 46020288)
-
(2007)
Nature Reviews Drug Discovery
, vol.6
, Issue.1
, pp. 75-92
-
-
Strand, V.1
Kimberly, R.2
Isaacs, J.D.3
-
79
-
-
36549065772
-
Biologics for the treatment of juvenile idiopathic arthritis: A systematic review and critical analysis of the evidence
-
DOI 10.1007/s10067-007-0654-6
-
Gartlehner G, Hansen RA, Jonas BL, et al. Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence. Clin Rheumatol 2008; 27 (1): 67-76 (Pubitemid 350182680)
-
(2008)
Clinical Rheumatology
, vol.27
, Issue.1
, pp. 67-76
-
-
Gartlehner, G.1
Hansen, R.A.2
Jonas, B.L.3
Thieda, P.4
Lohr, K.N.5
-
80
-
-
55249084910
-
Update on biologics in juvenile idiopathic arthritis
-
Ilowite NT. Update on biologics in juvenile idiopathic arthritis. Curr Opin Rheumatol 2008; 20 (5): 613-8
-
(2008)
Curr. Opin. Rheumatol.
, vol.20
, Issue.5
, pp. 613-618
-
-
Ilowite, N.T.1
-
81
-
-
77955371398
-
Tumor necrosis factor alpha blockers and malignancy in children: Forty-eight cases reported to the food and drug administration
-
Diak P, Siegel J, La GL, et al. Tumor necrosis factor alpha blockers and malignancy in children: forty-eight cases reported to the Food and Drug Administration. Arthritis Rheum 2010; 62 (8): 2517-24
-
(2010)
Arthritis Rheum.
, vol.62
, Issue.8
, pp. 2517-2524
-
-
Diak, P.1
Siegel, J.2
La, G.L.3
-
82
-
-
77955385352
-
Should the Food and Drug Administration warning of malignancy in children receiving tumor necrosis factor alpha blockers change the way we treat children with juvenile idiopathic arthritis
-
Lehman TJ. Should the Food and Drug Administration warning of malignancy in children receiving tumor necrosis factor alpha blockers change the way we treat children with juvenile idiopathic arthritis? Arthritis Rheum 2010; 62 (8): 2183-4
-
(2010)
Arthritis Rheum.
, vol.62
, Issue.8
, pp. 2183-2184
-
-
Lehman, T.J.1
-
83
-
-
77953340599
-
Summary of worldwide pediatric malignancies reported after exposure to etanercept
-
McCroskery P, Wallace CA, Lovell DJ, et al. Summary of worldwide pediatric malignancies reported after exposure to etanercept. Pediatr Rheumatol Online J 2010; 8: 18
-
(2010)
Pediatr. Rheumatol. Online J.
, vol.8
, pp. 18
-
-
McCroskery, P.1
Wallace, C.A.2
Lovell, D.J.3
-
84
-
-
34250651691
-
Biologic therapies in juvenile idiopathic arthritis: Why and for whom
-
McCann LJ, Woo P. Biologic therapies in juvenile idiopathic arthritis: why and for whom? Acta Reumatol Port 2007; 32 (1): 15-26
-
(2007)
Acta. Reumatol. Port.
, vol.32
, Issue.1
, pp. 15-26
-
-
McCann, L.J.1
Woo, P.2
-
85
-
-
41649084155
-
At the horizon of innovative therapy in rheumatology: New biologic agents
-
DOI 10.1097/BOR.0b013e3282fa13b4, PII 0000228120080500000008
-
Finckh A. At the horizon of innovative therapy in rheumatology: new biologic agents. Curr Opin Rheumatol 2008; 20 (3): 269-75 (Pubitemid 351483315)
-
(2008)
Current Opinion in Rheumatology
, vol.20
, Issue.3
, pp. 269-275
-
-
Finckh, A.1
Gabay, C.2
-
86
-
-
0034673697
-
Etanercept in children with polyarticular juvenile rheumatoid arthritis
-
DOI 10.1056/NEJM200003163421103
-
Lovell DJ, Giannini EH, Reiff A, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 2000; 342 (11): 763-9 (Pubitemid 30151920)
-
(2000)
New England Journal of Medicine
, vol.342
, Issue.11
, pp. 763-769
-
-
Lovell, D.J.1
Giannini, E.H.2
Reiff, A.3
Cawkwell, G.D.4
Silverman, E.D.5
Nocton, J.J.6
Stein, L.D.7
Gedalia, A.8
Ilowite, N.T.9
Wallace, C.A.10
Whitmore, J.11
Finck, B.K.12
-
87
-
-
49949115223
-
Adalimumab with or without methotrexate in juvenile rheumatoid arthritis
-
Lovell DJ, Ruperto N, Goodman S, et al. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med 2008; 359 (8): 810-20
-
(2008)
N. Engl. J. Med.
, vol.359
, Issue.8
, pp. 810-820
-
-
Lovell, D.J.1
Ruperto, N.2
Goodman, S.3
-
88
-
-
34848884299
-
A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis
-
DOI 10.1002/art.22838
-
Ruperto N, Lovell DJ, Cuttica R, et al. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticularcourse juvenile rheumatoid arthritis. Arthritis Rheum 2007; 56 (9): 3096-106 (Pubitemid 47502757)
-
(2007)
Arthritis and Rheumatism
, vol.56
, Issue.9
, pp. 3096-3106
-
-
Ruperto, N.1
Lovell, D.J.2
Cuttica, R.3
Wilkinson, N.4
Woo, P.5
Espada, G.6
Wouters, C.7
Silverman, E.D.8
Balogh, Z.9
Henrickson, M.10
Apaz, M.-T.11
Baildam, E.12
Fasth, A.13
Gerloni, V.14
Lahdenne, P.15
Prieur, A.-M.16
Ravelli, A.17
Saurenmann, R.K.18
Gamir, M.L.19
Wulffraat, N.20
Marodi, L.21
Petty, R.E.22
Joos, R.23
Zulian, F.24
McCurdy, D.25
Myones, B.L.26
Nagy, K.27
Reuman, P.28
Szer, I.29
Travers, S.30
Beutler, A.31
Keenan, G.32
Clark, J.33
Visvanathan, S.34
Fasanmade, A.35
Raychaudhuri, A.36
Mendelsohn, A.37
Martini, A.38
Giannini, E.H.39
more..
-
89
-
-
40749152243
-
Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: A randomised, double-blind, placebo-controlled, withdrawal phase III trial
-
DOI 10.1016/S0140-6736(08)60454-7, PII S0140673608604547
-
Yokota S, Imagawa T, Mori M, et al. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet 2008; 371 (9617): 998-1006 (Pubitemid 351389534)
-
(2008)
The Lancet
, vol.371
, Issue.9617
, pp. 998-1006
-
-
Yokota, S.1
Imagawa, T.2
Mori, M.3
Miyamae, T.4
Aihara, Y.5
Takei, S.6
Iwata, N.7
Umebayashi, H.8
Murata, T.9
Miyoshi, M.10
Tomiita, M.11
Nishimoto, N.12
Kishimoto, T.13
-
90
-
-
43949143169
-
Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
-
DOI 10.1002/art.23427
-
Lovell DJ, Reiff A, Ilowite NT, et al. Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis. Arthritis Rheum 2008; 58 (5): 1496-504 (Pubitemid 351705939)
-
(2008)
Arthritis and Rheumatism
, vol.58
, Issue.5
, pp. 1496-1504
-
-
Lovell, D.J.1
Reiff, A.2
Ilowite, N.T.3
Wallace, C.A.4
Chon, Y.5
Lin, S.-L.6
Baumgartner, S.W.7
Giannini, E.H.8
-
91
-
-
66149142293
-
Long-term follow-up on effectiveness and safety of etanercept in JIA: The Dutch national register
-
Prince FH. Long-term follow-up on effectiveness and safety of etanercept in JIA: the Dutch national register. Ann Rheum Dis 2009; 68 (5): 635-41
-
(2009)
Ann. Rheum. Dis.
, vol.68
, Issue.5
, pp. 635-641
-
-
Prince, F.H.1
-
92
-
-
65249098979
-
Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis JIA: Preliminary data from the german jia registry
-
Horneff G. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry. Ann Rheum Dis 2009; 68 (4): 519-25
-
(2009)
Ann. Rheum. Dis.
, vol.68
, Issue.4
, pp. 519-525
-
-
Horneff, G.1
-
94
-
-
13444310439
-
Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor α monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: Results of an open-label prospective study
-
DOI 10.1002/art.20793
-
Gerloni V. Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study. Arthritis Rheum 2005; 52 (2): 548-53 (Pubitemid 40216319)
-
(2005)
Arthritis and Rheumatism
, vol.52
, Issue.2
, pp. 548-553
-
-
Gerloni, V.1
Pontikaki, I.2
Gattinara, M.3
Desiati, F.4
Lupi, E.5
Lurati, A.6
Salmaso, A.7
Fantini, F.8
-
95
-
-
0037370938
-
Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: An open label study
-
DOI 10.1136/ard.62.3.245
-
Lahdenne P. Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study. Ann Rheum Dis 2003; 62 (3): 245-7 (Pubitemid 36238089)
-
(2003)
Annals of the Rheumatic Diseases
, vol.62
, Issue.3
, pp. 245-247
-
-
Lahdenne, P.1
Vahasalo, P.2
Honkanen, V.3
-
96
-
-
0037388345
-
Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type
-
DOI 10.1002/art.10885
-
Quartier P. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 2003; 48 (4): 1093-101 (Pubitemid 36418252)
-
(2003)
Arthritis and Rheumatism
, vol.48
, Issue.4
, pp. 1093-1101
-
-
Quartier, P.1
Taupin, P.2
Bourdeaut, F.3
Lemelle, I.4
Pillet, P.5
Bost, M.6
Sibilia, J.7
Kone-Paut, I.8
Gandon-Laloum, S.9
LeBideau, M.10
Bader-Meunier, B.11
Mouy, R.12
Debre, M.13
Landais, P.14
Prieur, A.-M.15
-
97
-
-
9644255827
-
The German etanercept registry for treatment of juvenile idiopathic arthritis
-
DOI 10.1136/ard.2003.014886
-
Horneff G. The German etanercept registry for treatment of juvenile idiopathic arthritis. Ann Rheum Dis 2004; 63 (12): 1638-44 (Pubitemid 39573695)
-
(2004)
Annals of the Rheumatic Diseases
, vol.63
, Issue.12
, pp. 1638-1644
-
-
Horneff, G.1
Schmeling, H.2
Biedermann, T.3
Foeldvari, I.4
Ganser, G.5
Girschick, H.J.6
Hospach, T.7
Huppertz, H.I.8
Keilzer, R.9
Kuster, R.M.10
Michels, H.11
Moebius, D.12
Rogalski, B.13
Thon, A.14
-
98
-
-
62949147825
-
-
online Available from URL Accessed Feb 9
-
European Medicines Agency [online]. Available from URL: www.ema.europa.eu/ema [Accessed 2011 Feb 9]
-
(2011)
European Medicines Agency
-
-
-
99
-
-
31544465967
-
Systemic juvenile idiopathic arthritis: Diagnosis, management, and outcome
-
DOI 10.1038/ncprheum0084, PII N0084
-
Woo P. Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome. Nat Clin Pract Rheumatolol 2006; 2 (1): 28-34 (Pubitemid 43153646)
-
(2006)
Nature Clinical Practice Rheumatology
, vol.2
, Issue.1
, pp. 28-34
-
-
Woo, P.1
-
100
-
-
31544451391
-
Open label phase II trial of single ascending doses ofMRAin Caucasian children with severe systemic juvenile idiopathic arthritis: Proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement
-
Woo P.Open label phase II trial of single, ascending doses ofMRAin Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement. Arthritis Res Ther 2005; 7 (6): R1281-8
-
(2005)
Arthritis Res. Ther.
, vol.7
, Issue.6
-
-
Woo, P.1
-
102
-
-
39549109506
-
Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: Preliminary experience in France
-
DOI 10.1136/ard.2007.076034
-
Lequerre T. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Ann Rheum Dis 2008; 67 (3): 302-8 (Pubitemid 351281262)
-
(2008)
Annals of the Rheumatic Diseases
, vol.67
, Issue.3
, pp. 302-308
-
-
Lequerre, T.1
Quartier, P.2
Rosellini, D.3
Alaoui, F.4
De Bandt, M.5
Mejjad, O.6
Kone-Paut, I.7
Michel, M.8
Demis, E.9
Khellaf, M.10
Limai, N.11
Job-Deslandre, C.12
Fautrel, B.13
Le Loet, X.14
Sibilia, J.15
-
103
-
-
39549120448
-
Anakinra treatment for systemic juvenile idiopathic arthritis and adult onset Still disease
-
DOI 10.1136/ard.2007.082859
-
Woo P. Anakinra treatment for systemic juvenile idiopathic arthritis and adult onset Still disease. Ann Rheum Dis 2008; 67 (3): 281-2 (Pubitemid 351281258)
-
(2008)
Annals of the Rheumatic Diseases
, vol.67
, Issue.3
, pp. 281-282
-
-
Woo, P.1
-
104
-
-
43049158200
-
Anakinra treatment for systemic onset juvenile idiopathic arthritis SOJIA
-
Oxford
-
Ohlsson V. Anakinra treatment for systemic onset juvenile idiopathic arthritis (SOJIA). Rheumatology (Oxford) 2008; 47 (4): 555-6
-
(2008)
Rheumatology
, vol.47
, Issue.4
, pp. 555-556
-
-
Ohlsson, V.1
-
105
-
-
43949116263
-
The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis
-
DOI 10.1002/art.23437
-
Gattorno M. The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2008; 58 (5): 1505-15 (Pubitemid 351705940)
-
(2008)
Arthritis and Rheumatism
, vol.58
, Issue.5
, pp. 1505-1515
-
-
Gattorno, M.1
Piccini, A.2
Lasiglie, D.3
Tassi, S.4
Brisca, G.5
Carta, S.6
Delfino, L.7
Ferlito, F.8
Pelagatti, M.A.9
Caroli, F.10
Buoncompagni, A.11
Viola, S.12
Loy, A.13
Sironi, M.14
Vecchi, A.15
Ravelli, A.16
Martini, A.17
Rubartelli, A.18
-
109
-
-
11344266825
-
Treating children with arthritis: Towards an evidence-based culture
-
Feldman BM. Treating children with arthritis: towards an evidence-based culture. J Rheumatol Suppl 2005; 72: 33-5 (Pubitemid 40075951)
-
(2005)
Journal of Rheumatology
, vol.32
, Issue.SUPPL. 72
, pp. 33-35
-
-
Feldman, B.M.1
-
110
-
-
79955097117
-
-
online Available from URL; Accessed Feb 9
-
Medicines for Children Research Network [online]. Available from URL: http://mcrn.org.uk [Accessed 2011 Feb 9]
-
(2011)
Medicines for Children Research Network
-
-
|